• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AD 0.00% 1.8¢

ADALTA LIMITED

AdAlta Limited is an Australia-based clinical-stage biotechnology company. The Company... AdAlta Limited is an Australia-based clinical-stage biotechnology company. The Company uses its i-body platform to discover and develop protein therapeutics addressing drug targets that are challenging for other technologies. The Company's first-in-class lead asset, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases, for which current therapies are sub-optimal. AD-214 is an Fc-Fusion protein that contains two AD-114 i-body molecules at the front end, that bind with high affinity to the human target, CXCR4. It is also engaged in developing i-body enabled Chimeric antigen receptor T cell (CAR-T) cells. It co-develops i-bodies as diagnostic imaging agents (i-PET imaging) against Granzyme B, a biomarker of response to immuno-oncology drugs.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
1AD 12/03/19 0 124
12/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  124 
1AD 28/02/19 0 85
28/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  85 
1AD 28/02/19 0 202
28/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  202 
1AD
News: 1AD Adalta Ltd Says Formed Collaborative Partnership With Excellerate Bioscience
28/02/19 0 75
28/02/19 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  75 
1AD 31/01/19 0 199
31/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  199 
1AD 29/01/19 0 189
29/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  189 
1AD 22/01/19 0 186
22/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  186 
1AD 21/01/19 0 147
21/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  147 

See All Discussions arrow Created with Sketch.
(20min delay)
Last
1.8¢
Change
0.000(0.00%)
Mkt cap ! $11.51M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
3 619832 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 402117 2
View Market Depth
Last trade - 09.59am 04/12/2024 (20 minute delay) ?
Last
1.8¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
1.7¢ 1.8¢ 1.7¢ 107376
Last updated 11.43am 04/12/2024 ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.